Literature DB >> 4043582

An analysis of epidemiological data in HLA-typed diabetic children.

A Mustonen, J Ilonen, A Tiilikainen, M Kataja, H K Akerblom.   

Abstract

To clarify the heterogeneity of Type 1 (insulin-dependent) diabetes mellitus, differences between patients with different HLA risk antigens were investigated with regard to sex, age at diagnosis, season of year and calendar year at diagnosis of the disease. The study consisted of 293 HLA-typed patients from the Department of Paediatrics, University of Oulu, Oulu, Finland. HLA-Dw2 was extremely rare among diabetic patients, whereas Dw3 and Dw4 were associated with increased risk in this as in other series. Male patients more often had the HLA-A1 antigen than females. On comparison of the Dw3 positive patients, boys more frequently had the combination A1,B8 than girls. A1,B8-positive patients were more often diagnosed during the warm months, in the late summer and autumn. Patients with both Dw3 and Dw4 were younger at diagnosis when compared with the rest of the patients. The results support the concept of heterogeneity in the pathogenesis of Type 1 diabetes associated with HLA-linked genetic determinants.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043582     DOI: 10.1007/bf00280881

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  Estimability and estimation in case-referent studies.

Authors:  O Miettinen
Journal:  Am J Epidemiol       Date:  1976-02       Impact factor: 4.897

2.  HLA-DR typing in identical twins with insulin-dependent diabetes: difference between concordant and discordant pairs.

Authors:  C Johnston; D A Pyke; A G Cudworth; E Wolf
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

Review 3.  The genetic susceptibility to type I (insulin-dependent) diabetes mellitus.

Authors:  A G Cudworth; E Wolf
Journal:  Clin Endocrinol Metab       Date:  1982-07

4.  HLA-Dw1 and BfF as protective markers in multiple sclerosis.

Authors:  J Ilonen; A Lagerstedt; S Koskimies; M Reunanen
Journal:  J Neuroimmunol       Date:  1983-12       Impact factor: 3.478

5.  Increase of HLA haplotype A9-Bw16 in familial insulin-dependent diabetes mellitus in northern-Finland.

Authors:  J Ilonen; H K Akerblom; A Tiilikainen; A Mustonen; E Herva; S Koskimies; K Kouvalainen
Journal:  Acta Diabetol Lat       Date:  1982 Apr-Jun

6.  Prevalence and ten-year (1970-1979) incidence of insulin-dependent diabetes mellitus in children and adolescents in Finland.

Authors:  A Reunanen; H K Akerblom; M L Käär
Journal:  Acta Paediatr Scand       Date:  1982-11

7.  A new look at HLA genetics with particular reference to type-1 diabetes.

Authors:  A G Cudworth; E Wolf; A N Gorsuch; H Festenstein
Journal:  Lancet       Date:  1979-08-25       Impact factor: 79.321

8.  A 'new' DR4 associated D specificity 'JA' in type 1 (insulin-dependent) diabetes: A9, Bw16, DJA, DR4 haplotype.

Authors:  A Mustonen; J Ilonen; H M Surcel; H K Akerblom
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

9.  Seasonal onset of insulin dependent diabetes in relation to sex and age at onset.

Authors:  R S Gray; L J Duncan; B F Clarke
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

10.  The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.

Authors:  E Wolf; K M Spencer; A G Cudworth
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

View more
  10 in total

Review 1.  Latent autoimmune diabetes in adults (LADA).

Authors:  Ramachandra G Naik; Jerry P Palmer
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  Autoimmune diabetes: more than just one flavor?

Authors:  H K Chiu; J P Palmer
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

3.  Two distinct HLA-DR3 haplotypes are associated with age related heterogeneity in type 1 (insulin-dependent) diabetes.

Authors:  I Deschamps; A Marcelli-Barge; J C Poirier; O Cohen-Haguenauer; H Abderrahim; D Cohen; H Lestradet; J Hors
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

4.  Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity.

Authors:  Bimota Nambam; Shakti Aggarwal; Anju Jain
Journal:  World J Diabetes       Date:  2010-09-15

5.  The Swedish childhood diabetes study--results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders.

Authors:  G Dahlquist; L Blom; T Tuvemo; L Nyström; A Sandström; S Wall
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

6.  Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates.

Authors:  Lisa M Emery; Sunanda Babu; Teodorica L Bugawan; Jill M Norris; Henry A Erlich; George S Eisenbarth; Marian Rewers
Journal:  Pediatr Diabetes       Date:  2005-09       Impact factor: 4.866

7.  Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.

Authors:  J C Ongagna; C Levy-Marchal
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

8.  Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes.

Authors:  M Knip; J Ilonen; A Mustonen; H K Akerblom
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

9.  Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in northern than in southern Europe.

Authors:  U Samuelsson; J Ludvigsson; G F Bottazzo; M Shattock; S Adolfsson; D Becker; E Cacciari; F Chiarelli; G Chiumello; I Deschamps
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

Review 10.  Genetic Modifiers of Thymic Selection and Central Tolerance in Type 1 Diabetes.

Authors:  Stephan Kissler
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.